Literature DB >> 16256873

On defining aspirin resistance.

David J Schneider.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16256873     DOI： 10.1016/j.jacc.2005.08.014

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  3 in total

Review 1.  Aspirin for primary prevention of cardiovascular disease in diabetes mellitus.

Authors:  Michael Pignone; Craig D Williams
Journal:  Nat Rev Endocrinol       Date:  2010-09-21       Impact factor: 43.330

2.  Gemfibrozil and its combination with metformin on pleiotropic effect on IL-10 and adiponectin and anti-atherogenic treatment in insulin resistant type 2 diabetes mellitus rats.

Authors:  Ashish Kumar Sharma; Sachin Kumar Raikwar; Muneem Kumar Kurmi; Bharthu Parthsarthi Srinivasan
Journal:  Inflammopharmacology       Date:  2012-10-31       Impact factor: 4.473

Review 3.  Pharmacokinetic and Pharmacodynamic Profile of a Novel Phospholipid Aspirin Formulation.

Authors:  Dominick J Angiolillo; Jayne Prats; Efthymios N Deliargyris; David J Schneider; James Scheiman; Carey Kimmelstiel; Ph Gabriel Steg; Mark Alberts; Todd Rosengart; Roxana Mehran; Deepak L Bhatt
Journal:  Clin Pharmacokinet       Date:  2022-01-20       Impact factor: 6.447
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.